Publication:
Verapamil blocks scopolamine enhancement effect on memory consolidation in passive avoidance task in rats

dc.contributor.authorGiménez de Béjar, Verónica
dc.contributor.authorCaballero Bleda, María
dc.contributor.authorPopovic, Natalija
dc.contributor.authorPopovic Popovic, Miroljub
dc.contributor.departmentAnatomía Humana y Psicobiología
dc.date.accessioned2024-06-18T10:36:32Z
dc.date.available2024-06-18T10:36:32Z
dc.date.issued2017-08-23
dc.description© 2017 Giménez De Béjar, Caballero Bleda, Popovic and Popovic. This manuscript version is made available under the CC-BY 4.0 license http://creativecommons.org/licenses/by/4.0/. This document is the Published version of a Published Work that appeared in final form in Frontiers in Pharmacology. To access the final edited and published work see https://doi.org/10.3389/fphar.2017.00566
dc.description.abstractOur recent data have indicated that scopolamine, a non-selective muscarinic receptor antagonist, improves memory consolidation, in a passive avoidance task, tested in rats. It has been found that verapamil, a phenylalkylamine class of the L-type voltage-dependent calcium channel antagonist, inhibits [3H] N-methyl scopolamine binding to M1 muscarinic receptors. However, there are no data about the effect of verapamil on memory consolidation in the passive avoidance task, in rats. The purpose of the present study was to examine the effects of verapamil (0.5, 1.0, 2.5, 5.0, 10, or 20 mg/kg i.p.) as well as the interaction between scopolamine and verapamil on memory consolidation in the step-through passive avoidance task, in Wistar rats. Our results showed that verapamil (1.0 and 2.5 mg/kg) administered immediately after the acquisition task significantly increased the latency of the passive avoidance response, on the 48 h retested trial, improving memory consolidation. On the other hand, verapamil in a dose of 5 mg/kg, that per se does not affect memory consolidation, significantly reversed the memory consolidation improvement induced by scopolamine (1 mg/kg, i.p., administered immediately after verapamil treatment) but did not change the passive avoidance response in rats treated by an ineffective dose of scopolamine (30 mg/kg). In conclusion, the present data suggest that (1) the post-training administration of verapamil, dose-dependently, improves the passive avoidance response; (2) verapamil, in ineffective dose, abolished the improvement of memory consolidation effect of scopolamine; and (3) exists interaction between cholinergic muscarinic receptors and calcium homeostasis-related mechanisms in the consolidation of emotional memory.es
dc.formatapplication/pdfes
dc.format.extent9es
dc.identifier.citationFront Pharmacol. 2017 8:566.
dc.identifier.doihttps://doi.org/10.3389/fphar.2017.00566
dc.identifier.issnElectronic: 1663-9812
dc.identifier.urihttp://hdl.handle.net/10201/142386
dc.languageenges
dc.publisherFrontiers Mediaes
dc.relationFunding for this study was provided by the Health Council of Murcia Region, Spain (MC), the Spanish Ministry of Economy and Competitiveness (BFU2014-57516-P; LPL, JLF), and the European Regional Development Fund (EFDR; LPL). The funding source had no further role in the study design; in the collection, analysis, and interpretation of the data; in the writing of the report; or in the decision to submit the paper for publication.es
dc.relation.publisherversionhttps://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2017.00566/fulles
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectMemory consolidationes
dc.subjectPassive avoidancees
dc.subjectVerapamiles
dc.subjectScopolaminees
dc.subjectRates
dc.subject.otherCDU::6 - Ciencias aplicadases
dc.titleVerapamil blocks scopolamine enhancement effect on memory consolidation in passive avoidance task in ratses
dc.typeinfo:eu-repo/semantics/articlees
dspace.entity.typePublicationes
relation.isAuthorOfPublicationdc3015b4-805d-4b6e-a49f-f2d73bb3c2b2
relation.isAuthorOfPublication43b53091-f5bf-4b46-b164-88d2a3670e2f
relation.isAuthorOfPublication.latestForDiscoverydc3015b4-805d-4b6e-a49f-f2d73bb3c2b2
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Giménez de Béjar et al., Front. Pharmacol. 2017.pdf
Size:
2.16 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.26 KB
Format:
Item-specific license agreed upon to submission
Description:
Collections